Alignment Healthcare, Inc. Stock Price, News & Analysis

Alignment Healthcare (NASDAQ: ALHC) has achieved a significant milestone by being named to the 2025 Fortune 1000 list, marking its debut among America's largest public companies. The Medicare Advantage-focused company reported impressive financial results for FY2024, with total revenue reaching $2.7 billion, representing a 48.3% year-over-year growth. Notably, Alignment achieved its first full year of positive adjusted EBITDA as a public company. Founded in 2013, the company now serves 217,500 seniors across five states, with over 98% of members enrolled in 4-star or higher-rated plans. Alignment's success is attributed to its innovative senior-focused care model, combining 24/7 concierge support, integrated care delivery, and AI-enabled technology. The company stands out as the only Fortune 1000-ranked payer exclusively focused on Medicare Advantage.

Alignment Healthcare (NASDAQ: ALHC) has announced its participation in the upcoming William Blair 45th Annual Growth Stock Conference. The company's presentation is scheduled for Wednesday, June 4, at 2 p.m. CDT. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.

Alignment Healthcare (NASDAQ: ALHC) has received the 2025 PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug (MAPD) plan. The company was one of only two MAPD plans out of 633 eligible contracts to achieve this recognition, representing the top 1.3%. The award requires a minimum 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS's star ratings program.

The recognition marks Alignment's sixth time receiving this honor, having previously won the PQA Excellence in Quality Award from 2018 to 2022. The company achieved perfect ratings in medication adherence for diabetes, hypertension, and cholesterol medications, as well as in medication therapy management program completion and statin use in persons with diabetes.

Alignment Healthcare (NASDAQ: ALHC) reported strong Q1 2025 financial results, exceeding expectations across key metrics. Revenue grew 47.5% YoY to $926.9 million, while Medicare Advantage membership increased 31.7% to 217,500 members. The company posted an adjusted EBITDA of $20.2 million, though it recorded a net loss of $9.4 million. The medical benefits ratio was 88.4%. Based on strong performance, ALHC raised its 2025 guidance midpoints for membership (228,000-233,000), revenue ($3,770M-$3,815M), and adjusted EBITDA ($38M-$60M). Additionally, the company announced a CFO transition, with Thomas Freeman stepping down after 8 years to become Strategic Advisor to the CEO, replaced by Jim Head, formerly CFO at Claritev.

Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the BofA Securities Healthcare Conference. The presentation is scheduled for Wednesday, May 14, at 2:20 p.m. PDT.

Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.

Alignment Healthcare (NASDAQ: ALHC) has announced two key leadership appointments to enhance its AI-enabled Medicare Advantage platform. Dr. Arta Bakshandeh has been named President of AVA®, the company's proprietary platform that utilizes 200+ data sources and 13,000+ attributes for personalized healthcare insights. Aly Duzich has been promoted to Chief Experience Officer to optimize member experience.

AVA platform leverages trusted AI to improve senior health outcomes and quality of care while reducing costs. The company has grown to over 200,000 health plan members since its IPO in March 2021. Both appointments aim to strengthen Alignment's care management and service delivery approach, integrating technology with compassionate care for seniors.

Alignment Healthcare (NASDAQ: ALHC) has scheduled the release of its first quarter 2025 financial results for Thursday, May 1, 2025, after market close. The company will host a conference call at 5 p.m. EDT to discuss the results.

Investors and interested parties can access a live audio webcast of the conference call through the company's investor relations website at https://ir.alignmenthealth.com/. The webcast replay will be available for approximately 12 months after the call.

Sutter Health and Alignment Healthcare (NASDAQ: ALHC) have renewed their strategic partnership, ensuring continued in-network access to Sutter's healthcare network for Alignment's Medicare Advantage members in Northern California. The agreement covers members enrolled in Sutter Advantage HMO and My Choice PPO health plans across 10 counties.

Sutter Health plans to expand its healthcare infrastructure starting in 2025, including:

• 27 new ambulatory care sites
• 27 urgent care centers
• 22 ambulatory surgery centers

The collaboration combines Sutter Health's provider network with Alignment's care model and AVA® technology platform, focusing on serving high-risk individuals with chronic conditions. The partnership spans across Placer, Sacramento, San Francisco, San Joaquin, San Mateo, Santa Clara, Santa Cruz, Sonoma, Stanislaus, and Yolo counties.

Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation in two major healthcare conferences in March 2025. The company will present at the Leerink Global Healthcare Conference on Tuesday, March 11, at 3:40 p.m. EDT, followed by a presentation at the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, at 10:30 a.m. EDT.

Both presentations will be accessible via webcast, with replays available on Alignment's investor relations website at ir.alignmenthealth.com.